18th International Conference On Solid Compounds Of Transition Elements ( 8:00 am )
The International Conference on Solid Compounds of Transition Elements (SCTE) is a forum that provides an open and informal discussion of fundamental and applied research in the areas of solid state chemistry, physics and materials science of compounds containing d- and f- elements. Main topics addressed include: * processes and syntheses; * crystal chemistry; * phase equilibria; * thermodynamics; * magnetic and electrical properties; * theory, electronic structure, chemical bonding; * applications. Intermetallic compounds such as hydrides, borides, carbides, silicides and homologues, pnictides, as well as chalcogenides, oxides and halides (especially those of low oxidation state exhibiting metal or semimetal properties) are usually covered. In particular, SCTE aims to emphasize presentations of on-going research projects by young researchers and PhD students, to assess the latest progress in this field, and to stimulate new collaborative projects.

Contact Info : phone# +35-21-994-6185 Email : Url: http://www.scte2012.itn.pt

18th International Conference On Solid Compounds Of Transition Elements ( 8:00 am )
The International Conference on Solid Compounds of Transition Elements (SCTE) is a forum that provides an open and informal discussion of fundamental and applied research in the areas of solid state chemistry, physics and materials science of compounds containing d- and f- elements. Main topics addressed include: * processes and syntheses; * crystal chemistry; * phase equilibria; * thermodynamics; * magnetic and electrical properties; * theory, electronic structure, chemical bonding; * applications. Intermetallic compounds such as hydrides, borides, carbides, silicides and homologues, pnictides, as well as chalcogenides, oxides and halides (especially those of low oxidation state exhibiting metal or semimetal properties) are usually covered. In particular, SCTE aims to emphasize presentations of on-going research projects by young researchers and PhD students, to assess the latest progress in this field, and to stimulate new collaborative projects.

Contact Info : phone# +35-21-994-6185 Email : Url: http://www.scte2012.itn.pt

ISBioTech Annual Meeting ( 8:00 am )

The ISBioTech Annual Meeting is designed for the professionals responsible for developing and producing biologics worldwide, and covers the latest technologies and best practices needed for safe, effective, and consistent products. You’ll learn and share with the industry’s leading companies and the individuals actually doing the work in the labs and production suites.

We’ll focus on the critical operations and methods while stressing quality, efficiency, and reproducibility. Target operations will include cell banking, protein expression, scale-up, filtration, purification, and product characterization for vaccines, therapeutics, and viral gene vectors.

In addition, we’ll pay particular attention to the most effective use of process analytical technology, single-use systems, documentation, and training. Plus we’ll emphasize the vital importance of raw material management, validated shipping methods, and the prevention of cross-contamination. Meeting Topics » Cell Line Development and Characterization » Cell Expansion and Yield Optimization » Feed and Harvest Strategies » Contamination Detection and Prevention » Process Control and Documentation » Plasmid and Vector Development » Single-Use Systems » Cell Collection, Selection, and Transduction » Media and Assay Development » Filtration and Purification » Transportation and Storage » Product Characterization and Comparability » Quality By Design

Email : Url: http://www.isbiotech.org/annualmeeting.html

18th International Conference On Solid Compounds Of Transition Elements ( 8:00 am )
The International Conference on Solid Compounds of Transition Elements (SCTE) is a forum that provides an open and informal discussion of fundamental and applied research in the areas of solid state chemistry, physics and materials science of compounds containing d- and f- elements. Main topics addressed include: * processes and syntheses; * crystal chemistry; * phase equilibria; * thermodynamics; * magnetic and electrical properties; * theory, electronic structure, chemical bonding; * applications. Intermetallic compounds such as hydrides, borides, carbides, silicides and homologues, pnictides, as well as chalcogenides, oxides and halides (especially those of low oxidation state exhibiting metal or semimetal properties) are usually covered. In particular, SCTE aims to emphasize presentations of on-going research projects by young researchers and PhD students, to assess the latest progress in this field, and to stimulate new collaborative projects.

Contact Info : phone# +35-21-994-6185 Email : Url: http://www.scte2012.itn.pt

ISBioTech Annual Meeting ( 8:00 am )

The ISBioTech Annual Meeting is designed for the professionals responsible for developing and producing biologics worldwide, and covers the latest technologies and best practices needed for safe, effective, and consistent products. You’ll learn and share with the industry’s leading companies and the individuals actually doing the work in the labs and production suites.

We’ll focus on the critical operations and methods while stressing quality, efficiency, and reproducibility. Target operations will include cell banking, protein expression, scale-up, filtration, purification, and product characterization for vaccines, therapeutics, and viral gene vectors.

In addition, we’ll pay particular attention to the most effective use of process analytical technology, single-use systems, documentation, and training. Plus we’ll emphasize the vital importance of raw material management, validated shipping methods, and the prevention of cross-contamination. Meeting Topics » Cell Line Development and Characterization » Cell Expansion and Yield Optimization » Feed and Harvest Strategies » Contamination Detection and Prevention » Process Control and Documentation » Plasmid and Vector Development » Single-Use Systems » Cell Collection, Selection, and Transduction » Media and Assay Development » Filtration and Purification » Transportation and Storage » Product Characterization and Comparability » Quality By Design

Email : Url: http://www.isbiotech.org/annualmeeting.html

TRAC 39: Epigenetics ( 8:00 am )
Sequencing of the human genome was not the endpoint of our goal in understanding human genetics.  The chemical modifications to DNA and the chemical interactions involving the manufacture of proteins represents a second level of human genetics termed, epigenetics or epigenomics. Epigenetics refers to the study of heritable changes in gene expression that occur without a change in DNA sequence. Research has shown that epigenetic mechanisms provide an additional layer of transcriptional control that regulates how genes are expressed. Epigenetic abnormalities are associated with genetic disorders, cancer, autoimmune diseases, aging and pediatric syndromes, among others.

This course will address the basic principles of epigenetics, the role of epigenetic mechanisms in normal development and human disease, and the development of epigenetically-effective drugs. The objective of the program is to provide a solid foundation of information enabling participants to design experiments when returning to their own research lab. Furthermore to provide a solid background inorder to understand the literature in this rapidly growing field.

Participating instructors are primarily active researchers from neighboring institutes and universities who have been publishing in these areas for several years.


Topics: Lectures cover basic mechanism underlying DNA methylation, histone modification, chromatin organization, noncoding RNA, and gene repression. Moreover, a broad range of topics will be covered in epigenetic research including cancer, development, environmental health, and immunology. The lectures also provide the participant with practical information concerning current techniques in epigenetic research. For example, the application of CHARM, Illumina bead arrays, restriction enzyme analysis, and bisulfate sequencing is discussed in designing experiments and interpreting data.

In the laboratory, attendees gain hands-on experience in techniques including methyl specific PCR, chromatin immunoprecipitation, and global DNA methylation assays.

Contact Info : Bio-Trac Course Content and Custom Workshop Information Mark Nardone Director, Bio-Trac Program 301-496-2316 Email : Url: http://www.biotrac.com/

18th International Conference On Solid Compounds Of Transition Elements ( 8:00 am )
The International Conference on Solid Compounds of Transition Elements (SCTE) is a forum that provides an open and informal discussion of fundamental and applied research in the areas of solid state chemistry, physics and materials science of compounds containing d- and f- elements. Main topics addressed include: * processes and syntheses; * crystal chemistry; * phase equilibria; * thermodynamics; * magnetic and electrical properties; * theory, electronic structure, chemical bonding; * applications. Intermetallic compounds such as hydrides, borides, carbides, silicides and homologues, pnictides, as well as chalcogenides, oxides and halides (especially those of low oxidation state exhibiting metal or semimetal properties) are usually covered. In particular, SCTE aims to emphasize presentations of on-going research projects by young researchers and PhD students, to assess the latest progress in this field, and to stimulate new collaborative projects.

Contact Info : phone# +35-21-994-6185 Email : Url: http://www.scte2012.itn.pt

ISBioTech Annual Meeting ( 8:00 am )

The ISBioTech Annual Meeting is designed for the professionals responsible for developing and producing biologics worldwide, and covers the latest technologies and best practices needed for safe, effective, and consistent products. You’ll learn and share with the industry’s leading companies and the individuals actually doing the work in the labs and production suites.

We’ll focus on the critical operations and methods while stressing quality, efficiency, and reproducibility. Target operations will include cell banking, protein expression, scale-up, filtration, purification, and product characterization for vaccines, therapeutics, and viral gene vectors.

In addition, we’ll pay particular attention to the most effective use of process analytical technology, single-use systems, documentation, and training. Plus we’ll emphasize the vital importance of raw material management, validated shipping methods, and the prevention of cross-contamination. Meeting Topics » Cell Line Development and Characterization » Cell Expansion and Yield Optimization » Feed and Harvest Strategies » Contamination Detection and Prevention » Process Control and Documentation » Plasmid and Vector Development » Single-Use Systems » Cell Collection, Selection, and Transduction » Media and Assay Development » Filtration and Purification » Transportation and Storage » Product Characterization and Comparability » Quality By Design

Email : Bio-Trac Course Content and Custom Workshop Information Mark Nardone Director, Bio-Trac Program Url: http://www.isbiotech.org/annualmeeting.html

TRAC 39: Epigenetics ( 8:00 am )
Sequencing of the human genome was not the endpoint of our goal in understanding human genetics.  The chemical modifications to DNA and the chemical interactions involving the manufacture of proteins represents a second level of human genetics termed, epigenetics or epigenomics. Epigenetics refers to the study of heritable changes in gene expression that occur without a change in DNA sequence. Research has shown that epigenetic mechanisms provide an additional layer of transcriptional control that regulates how genes are expressed. Epigenetic abnormalities are associated with genetic disorders, cancer, autoimmune diseases, aging and pediatric syndromes, among others.

This course will address the basic principles of epigenetics, the role of epigenetic mechanisms in normal development and human disease, and the development of epigenetically-effective drugs. The objective of the program is to provide a solid foundation of information enabling participants to design experiments when returning to their own research lab. Furthermore to provide a solid background inorder to understand the literature in this rapidly growing field.

Participating instructors are primarily active researchers from neighboring institutes and universities who have been publishing in these areas for several years.


Topics: Lectures cover basic mechanism underlying DNA methylation, histone modification, chromatin organization, noncoding RNA, and gene repression. Moreover, a broad range of topics will be covered in epigenetic research including cancer, development, environmental health, and immunology. The lectures also provide the participant with practical information concerning current techniques in epigenetic research. For example, the application of CHARM, Illumina bead arrays, restriction enzyme analysis, and bisulfate sequencing is discussed in designing experiments and interpreting data.

In the laboratory, attendees gain hands-on experience in techniques including methyl specific PCR, chromatin immunoprecipitation, and global DNA methylation assays.

Contact Info : 301-496-2316 Email : Bio-Trac Course Content and Custom Workshop Information Mark Nardone Director, Bio-Trac Program Url: http://www.biotrac.com/

18th International Conference On Solid Compounds Of Transition Elements ( 8:00 am )
The International Conference on Solid Compounds of Transition Elements (SCTE) is a forum that provides an open and informal discussion of fundamental and applied research in the areas of solid state chemistry, physics and materials science of compounds containing d- and f- elements. Main topics addressed include: * processes and syntheses; * crystal chemistry; * phase equilibria; * thermodynamics; * magnetic and electrical properties; * theory, electronic structure, chemical bonding; * applications. Intermetallic compounds such as hydrides, borides, carbides, silicides and homologues, pnictides, as well as chalcogenides, oxides and halides (especially those of low oxidation state exhibiting metal or semimetal properties) are usually covered. In particular, SCTE aims to emphasize presentations of on-going research projects by young researchers and PhD students, to assess the latest progress in this field, and to stimulate new collaborative projects.

Contact Info : phone# +35-21-994-6185 Email : Url: http://www.scte2012.itn.pt

TRAC 39: Epigenetics ( 8:00 am )
Sequencing of the human genome was not the endpoint of our goal in understanding human genetics.  The chemical modifications to DNA and the chemical interactions involving the manufacture of proteins represents a second level of human genetics termed, epigenetics or epigenomics. Epigenetics refers to the study of heritable changes in gene expression that occur without a change in DNA sequence. Research has shown that epigenetic mechanisms provide an additional layer of transcriptional control that regulates how genes are expressed. Epigenetic abnormalities are associated with genetic disorders, cancer, autoimmune diseases, aging and pediatric syndromes, among others.

This course will address the basic principles of epigenetics, the role of epigenetic mechanisms in normal development and human disease, and the development of epigenetically-effective drugs. The objective of the program is to provide a solid foundation of information enabling participants to design experiments when returning to their own research lab. Furthermore to provide a solid background inorder to understand the literature in this rapidly growing field.

Participating instructors are primarily active researchers from neighboring institutes and universities who have been publishing in these areas for several years.


Topics: Lectures cover basic mechanism underlying DNA methylation, histone modification, chromatin organization, noncoding RNA, and gene repression. Moreover, a broad range of topics will be covered in epigenetic research including cancer, development, environmental health, and immunology. The lectures also provide the participant with practical information concerning current techniques in epigenetic research. For example, the application of CHARM, Illumina bead arrays, restriction enzyme analysis, and bisulfate sequencing is discussed in designing experiments and interpreting data.

In the laboratory, attendees gain hands-on experience in techniques including methyl specific PCR, chromatin immunoprecipitation, and global DNA methylation assays.

Contact Info : Bio-Trac Course Content and Custom Workshop Information Mark Nardone Director, Bio-Trac Program 301-496-2316 Email : Bio-Trac Course Content and Custom Workshop Information Mark Nardone Director, Bio-Trac Program Url: http://www.biotrac.com/

TRAC 39: Epigenetics ( 8:00 am )
Sequencing of the human genome was not the endpoint of our goal in understanding human genetics.  The chemical modifications to DNA and the chemical interactions involving the manufacture of proteins represents a second level of human genetics termed, epigenetics or epigenomics. Epigenetics refers to the study of heritable changes in gene expression that occur without a change in DNA sequence. Research has shown that epigenetic mechanisms provide an additional layer of transcriptional control that regulates how genes are expressed. Epigenetic abnormalities are associated with genetic disorders, cancer, autoimmune diseases, aging and pediatric syndromes, among others.

This course will address the basic principles of epigenetics, the role of epigenetic mechanisms in normal development and human disease, and the development of epigenetically-effective drugs. The objective of the program is to provide a solid foundation of information enabling participants to design experiments when returning to their own research lab. Furthermore to provide a solid background inorder to understand the literature in this rapidly growing field.

Participating instructors are primarily active researchers from neighboring institutes and universities who have been publishing in these areas for several years.


Topics: Lectures cover basic mechanism underlying DNA methylation, histone modification, chromatin organization, noncoding RNA, and gene repression. Moreover, a broad range of topics will be covered in epigenetic research including cancer, development, environmental health, and immunology. The lectures also provide the participant with practical information concerning current techniques in epigenetic research. For example, the application of CHARM, Illumina bead arrays, restriction enzyme analysis, and bisulfate sequencing is discussed in designing experiments and interpreting data.

In the laboratory, attendees gain hands-on experience in techniques including methyl specific PCR, chromatin immunoprecipitation, and global DNA methylation assays.

Contact Info : 301-496-2316 Email : Bio-Trac Course Content and Custom Workshop Information Mark Nardone Director, Bio-Trac Program Url: http://www.biotrac.com/

Analytical Techniques For The Quantitation Of Angiogenesis And Lymphoangiogenesis ( 8:00 am )

The growth of blood vessels, a process known as angiogenesis, is essential in normal physiology and its imbalance contributes to numerous disorders including cancer and age-related macular degeneration. Antiangiogenic compounds are regarded as a very promising therapeutic tools for treatment of cancer and several other disorders.

This four day training course focuses on analytical techniques used to assess the in vitro/in vivo growth of blood vessel and lymphatic endothelial cells.

The course will be structured to have a combination of wet labs and lectures covering this subject matter. Hands-on operational training of the following techniques will be covered: 1) Chorioallantoic Membrane Assay (CAM), 2) Rat Aortic Ring Assay, 3) Directed In Vivo Angiogenesis Assay (DIVAA), 4) Endothelial Cell Migration Assay and 5) Endothelial Cell Tube Formation Assay.

Lecture Titles:

Angiogenesis and it's Regulation by Redox Signaling; Angiogenesis and Tumor Endothelial Markers (TEM); Therapies Targeting Tumor Angiogenesis; Imaginng of Lymphangiogenesis; ECIS - A Morphological Biosensor for Cell Research; DIVVA: A Novel Method for Measuring Angiogenesis

Laboratory Topics:

Rat Aortic Ring Assay; Chick embryo chorioallantoic membrane (CAM) Assay; Tube Formation Assay; Growth Assay with Fluorescent Cells; Adhesion, Migration (ECIS) Tube Formation Assay; DIVVA CAM Assay

Contact Info : 301-496-2316 Email : Bio-Trac Course Content and Custom Workshop Information Mark Nardone Director, Bio-Trac Program Url: http://www.biotrac.com/

Lyophilisation & Spray Drying Summit ( 8:00 am )

Optimizing Technologies in Lyophilisation & Spray Drying for Pharmaceuticals and Biologics

Our Lyophilisation Conference will encompass six scientific areas:

• Developments in process analytical technologies (PAT) in freeze drying of parenteral products
• Practical formulation and process development of freeze-dried & spray dried products
• Overcome challenges in lyophilisation & spray drying by computer modeling
• Examine freeze drying & spray drying biologics
• Ensuring durability and improving quality through engineering techniques
• Management & strategy techniques to remain competitive

Contact Info : Novotel West London Hotel, London UK. Url: http://www.appelconsulting.co.uk/services/products

THE WORLD'S LARGEST VACCINE PARTNERING EVENT ( 8:00 am )


Contact Info : Terrapinn Ltd Wren House 43 Hatton Garden London EC1N 8EL Tel: +44 (0)20 7092 1000 Fax: +44 (0)20 7242 1508 Email : Url: http://www.terrapinn.com/

Analytical Techniques For The Quantitation Of Angiogenesis And Lymphoangiogenesis ( 8:00 am )

The growth of blood vessels, a process known as angiogenesis, is essential in normal physiology and its imbalance contributes to numerous disorders including cancer and age-related macular degeneration. Antiangiogenic compounds are regarded as a very promising therapeutic tools for treatment of cancer and several other disorders.

This four day training course focuses on analytical techniques used to assess the in vitro/in vivo growth of blood vessel and lymphatic endothelial cells.

The course will be structured to have a combination of wet labs and lectures covering this subject matter. Hands-on operational training of the following techniques will be covered: 1) Chorioallantoic Membrane Assay (CAM), 2) Rat Aortic Ring Assay, 3) Directed In Vivo Angiogenesis Assay (DIVAA), 4) Endothelial Cell Migration Assay and 5) Endothelial Cell Tube Formation Assay.

Lecture Titles:

Angiogenesis and it's Regulation by Redox Signaling; Angiogenesis and Tumor Endothelial Markers (TEM); Therapies Targeting Tumor Angiogenesis; Imaginng of Lymphangiogenesis; ECIS - A Morphological Biosensor for Cell Research; DIVVA: A Novel Method for Measuring Angiogenesis

Laboratory Topics:

Rat Aortic Ring Assay; Chick embryo chorioallantoic membrane (CAM) Assay; Tube Formation Assay; Growth Assay with Fluorescent Cells; Adhesion, Migration (ECIS) Tube Formation Assay; DIVVA CAM Assay

Contact Info : Bio-Trac Course Content and Custom Workshop Information Mark Nardone Director, Bio-Trac Program 301-496-2316 Email : Url: http://www.biotrac.com/

Lyophilisation & Spray Drying Summit ( 8:00 am )

Optimizing Technologies in Lyophilisation & Spray Drying for Pharmaceuticals and Biologics

Our Lyophilisation Conference will encompass six scientific areas:

• Developments in process analytical technologies (PAT) in freeze drying of parenteral products
• Practical formulation and process development of freeze-dried & spray dried products
• Overcome challenges in lyophilisation & spray drying by computer modeling
• Examine freeze drying & spray drying biologics
• Ensuring durability and improving quality through engineering techniques
• Management & strategy techniques to remain competitive

Contact Info : Novotel West London Hotel, London UK. Url: http://www.appelconsulting.co.uk/services/products

THE WORLD'S LARGEST VACCINE PARTNERING EVENT ( 8:00 am )


Contact Info : Terrapinn Ltd Wren House 43 Hatton Garden London EC1N 8EL Tel: +44 (0)20 7092 1000 Fax: +44 (0)20 7242 1508 Email : Url: http://www.terrapinn.com/

World Pediatric Drugs Congress ( 8:00 am )

The World Pediatric Drugs Congress brings together regulators, industry and academia to strategically improve pediatric drug development.

This conference focuses on developing the best quality therapeutics for children – guidance from government and cost efficiency for manufacturers.

Register now to learn from and to meet with decision-makers from key stakeholders in pediatric drugs.

Contact Info : http://www.terrapinn.com/template/live/documents.aspx?e=5113 Url: https://secure.terrapinn.com/V5/calc.aspx?E=5113

Analytical Techniques For The Quantitation Of Angiogenesis And Lymphoangiogenesis ( 8:00 am )

The growth of blood vessels, a process known as angiogenesis, is essential in normal physiology and its imbalance contributes to numerous disorders including cancer and age-related macular degeneration. Antiangiogenic compounds are regarded as a very promising therapeutic tools for treatment of cancer and several other disorders.

This four day training course focuses on analytical techniques used to assess the in vitro/in vivo growth of blood vessel and lymphatic endothelial cells.

The course will be structured to have a combination of wet labs and lectures covering this subject matter. Hands-on operational training of the following techniques will be covered: 1) Chorioallantoic Membrane Assay (CAM), 2) Rat Aortic Ring Assay, 3) Directed In Vivo Angiogenesis Assay (DIVAA), 4) Endothelial Cell Migration Assay and 5) Endothelial Cell Tube Formation Assay.

Lecture Titles:

Angiogenesis and it's Regulation by Redox Signaling; Angiogenesis and Tumor Endothelial Markers (TEM); Therapies Targeting Tumor Angiogenesis; Imaginng of Lymphangiogenesis; ECIS - A Morphological Biosensor for Cell Research; DIVVA: A Novel Method for Measuring Angiogenesis

Laboratory Topics:

Rat Aortic Ring Assay; Chick embryo chorioallantoic membrane (CAM) Assay; Tube Formation Assay; Growth Assay with Fluorescent Cells; Adhesion, Migration (ECIS) Tube Formation Assay; DIVVA CAM Assay

Contact Info : 301-496-2316 Email : Url: http://www.biotrac.com/

THE WORLD'S LARGEST VACCINE PARTNERING EVENT ( 8:00 am )


Contact Info : Terrapinn Ltd Wren House 43 Hatton Garden London EC1N 8EL Tel: +44 (0)20 7092 1000 Fax: +44 (0)20 7242 1508 Email : Url: http://www.terrapinn.com/

World Pediatric Drugs Congress ( 8:00 am )

The World Pediatric Drugs Congress brings together regulators, industry and academia to strategically improve pediatric drug development.

This conference focuses on developing the best quality therapeutics for children – guidance from government and cost efficiency for manufacturers.

Register now to learn from and to meet with decision-makers from key stakeholders in pediatric drugs.

Contact Info : http://www.terrapinn.com/template/live/documents.aspx?e=5113 Url: https://secure.terrapinn.com/V5/calc.aspx?E=5113

Analytical Techniques For The Quantitation Of Angiogenesis And Lymphoangiogenesis ( 8:00 am )

The growth of blood vessels, a process known as angiogenesis, is essential in normal physiology and its imbalance contributes to numerous disorders including cancer and age-related macular degeneration. Antiangiogenic compounds are regarded as a very promising therapeutic tools for treatment of cancer and several other disorders.

This four day training course focuses on analytical techniques used to assess the in vitro/in vivo growth of blood vessel and lymphatic endothelial cells.

The course will be structured to have a combination of wet labs and lectures covering this subject matter. Hands-on operational training of the following techniques will be covered: 1) Chorioallantoic Membrane Assay (CAM), 2) Rat Aortic Ring Assay, 3) Directed In Vivo Angiogenesis Assay (DIVAA), 4) Endothelial Cell Migration Assay and 5) Endothelial Cell Tube Formation Assay.

Lecture Titles:

Angiogenesis and it's Regulation by Redox Signaling; Angiogenesis and Tumor Endothelial Markers (TEM); Therapies Targeting Tumor Angiogenesis; Imaginng of Lymphangiogenesis; ECIS - A Morphological Biosensor for Cell Research; DIVVA: A Novel Method for Measuring Angiogenesis

Laboratory Topics:

Rat Aortic Ring Assay; Chick embryo chorioallantoic membrane (CAM) Assay; Tube Formation Assay; Growth Assay with Fluorescent Cells; Adhesion, Migration (ECIS) Tube Formation Assay; DIVVA CAM Assay

Contact Info : 301-496-2316 Email : Url: http://www.biotrac.com/

THE WORLD'S LARGEST VACCINE PARTNERING EVENT ( 8:00 am )


Contact Info : Terrapinn Ltd Wren House 43 Hatton Garden London EC1N 8EL Tel: +44 (0)20 7092 1000 Fax: +44 (0)20 7242 1508 Email : Url: http://www.terrapinn.com/

BIO IP Counsels Committee Conference ( 8:00 am )

IP Counsels Committee Conference Overview

Over the past nine years, BIO's semiannual IP Counsels Committee Conference has become a popular and growing event among our members' IP and legal professionals. Our upcoming 2012 Spring IPCC Conference in Austin, Texas will be an excellent opportunity for IP professionals to hear, listen, and learn about current and projected topics related to biotechnology IP.

We invite you to join us in an informal, fun and informative setting to meet fellow in-house legal and IP professionals, to make new acquaintances, to reconnect with old friends in the industry, and to take home a wealth of information - and maybe some new ideas.

Contact Info : Caroline Boch (202) 962-9228 Email : Url: http://login.bio.org/?redirectKey=product&extra=1423

Biologics World Korea ( 8:00 am )

Biologics World Korea provides the ONLY biologics and biosimilars focused platform in Korea that brings together Korean and international biopharma leaders, innovative biotechs, and technocrats to convene and discuss on strategies, latest technologies and best practices.

Biologics World Korea 2012 brings you:

• The most targeted platform to meet Korean and international biologics manufacturers

• Case studies and discussions from senior level decision makers who will influence the direction of Korea's biologics industry

• Both strategic and technology-focused biologics development in Korea

Biologics World Korea 2012 Key topics include:

• Opportunities and challenges facing Korea Biologics Industry

• Innovation highlights: Biobetters and novel biologics development in Korea

• Innovation highlights: Vaccine Development in Korea

• Biomanufacturing upstream best practices

• Biomanufacturing downstream best practices

• Operational excellence and PAT

• Crystalballing the future of Korean industry

Contact Info : Jasmine Wong +65 6493 1598 Email : Url: http://www.imapac.com/index.php?page=Biologics-World-Korea-2012Enquiry

Future Diagnostics Conference ( 8:00 am )

Presented by the Chao Family Comprehensive Cancer Center and Cambridge Healthtech Institute and held at the University of California, Irvine Student Center

A number of breakthrough technologies are being incorporated into novel diagnostics to detect a range of molecular and protein biomarkers.  The diagnostic methods applied will include PCR, microarrays, sequencing, proteomics, methylation, and mutation detection. This meeting will highlight the next generation of diagnostic platforms that encompass the latest trends in microfluidics, point-of-care technologies, in vivo sensing, and consumer-driven products.  A panel of experts will focus on translation to the medical community and the key to success in implementation.

Topics include:

• Microfluidic Technology and Business Trends
• Point-of-Care Diagnostics
• Nanotechnology Advances
• Innovation in Microfluidics
• In vivo Diagnostic Imaging
• Recent Approvals of Companion Diagnostics

Scientific Advisory Board:

• John C. Carrano, Ph.D., President, Carrano Consulting, LLC
• John J. Krolewski, M.D., Ph.D., Professor, Pathology & Laboratory Medicine, University of California, Irvine
• Young Jik Kwon, Ph.D., Associate Professor, Department of Pharmaceutical Sciences, Department of Chemical Engineering and Materials Science, University of California, Irvine
• Frank L. Meyskens, Jr., M.D., Director, Chao Family Cancer Center, University of California, Irvine
• Edward L. Nelson, M.D., FACP, Chief, Heme/Onc Division, Associate Professor, Medicine and of Molecular Biology & Biochemistry, University of California, Irvine
• Jennifer Prescher, Ph.D., Assistant Professor, Departments of Chemistry, Molecular Biology & Biochemistry, University of California, Irvine
• Gregory A. Weiss, Ph.D., Professor, Departments of Chemistry, Molecular Biology & Biochemistry, University of California, Irvine | Conference Chairman

Url: http://www.healthtech.com/

BIO IP Counsels Committee Conference ( 8:00 am )

IP Counsels Committee Conference Overview

Over the past nine years, BIO's semiannual IP Counsels Committee Conference has become a popular and growing event among our members' IP and legal professionals. Our upcoming 2012 Spring IPCC Conference in Austin, Texas will be an excellent opportunity for IP professionals to hear, listen, and learn about current and projected topics related to biotechnology IP.

We invite you to join us in an informal, fun and informative setting to meet fellow in-house legal and IP professionals, to make new acquaintances, to reconnect with old friends in the industry, and to take home a wealth of information - and maybe some new ideas.

Contact Info : Caroline Boch (202) 962-9228 Email : Url: http://login.bio.org/?redirectKey=product&extra=1423

Biologics World Korea ( 8:00 am )

Biologics World Korea provides the ONLY biologics and biosimilars focused platform in Korea that brings together Korean and international biopharma leaders, innovative biotechs, and technocrats to convene and discuss on strategies, latest technologies and best practices.

Biologics World Korea 2012 brings you:

• The most targeted platform to meet Korean and international biologics manufacturers

• Case studies and discussions from senior level decision makers who will influence the direction of Korea's biologics industry

• Both strategic and technology-focused biologics development in Korea

Biologics World Korea 2012 Key topics include:

• Opportunities and challenges facing Korea Biologics Industry

• Innovation highlights: Biobetters and novel biologics development in Korea

• Innovation highlights: Vaccine Development in Korea

• Biomanufacturing upstream best practices

• Biomanufacturing downstream best practices

• Operational excellence and PAT

• Crystalballing the future of Korean industry

Contact Info : Jasmine Wong +65 6493 1598 Email : Url: http://www.imapac.com/index.php?page=Biologics-World-Korea-2012Enquiry

Future Diagnostics Conference ( 8:00 am )

Presented by the Chao Family Comprehensive Cancer Center and Cambridge Healthtech Institute and held at the University of California, Irvine Student Center

A number of breakthrough technologies are being incorporated into novel diagnostics to detect a range of molecular and protein biomarkers.  The diagnostic methods applied will include PCR, microarrays, sequencing, proteomics, methylation, and mutation detection. This meeting will highlight the next generation of diagnostic platforms that encompass the latest trends in microfluidics, point-of-care technologies, in vivo sensing, and consumer-driven products.  A panel of experts will focus on translation to the medical community and the key to success in implementation.

Topics include:

• Microfluidic Technology and Business Trends
• Point-of-Care Diagnostics
• Nanotechnology Advances
• Innovation in Microfluidics
• In vivo Diagnostic Imaging
• Recent Approvals of Companion Diagnostics

Scientific Advisory Board:

• John C. Carrano, Ph.D., President, Carrano Consulting, LLC
• John J. Krolewski, M.D., Ph.D., Professor, Pathology & Laboratory Medicine, University of California, Irvine
• Young Jik Kwon, Ph.D., Associate Professor, Department of Pharmaceutical Sciences, Department of Chemical Engineering and Materials Science, University of California, Irvine
• Frank L. Meyskens, Jr., M.D., Director, Chao Family Cancer Center, University of California, Irvine
• Edward L. Nelson, M.D., FACP, Chief, Heme/Onc Division, Associate Professor, Medicine and of Molecular Biology & Biochemistry, University of California, Irvine
• Jennifer Prescher, Ph.D., Assistant Professor, Departments of Chemistry, Molecular Biology & Biochemistry, University of California, Irvine
• Gregory A. Weiss, Ph.D., Professor, Departments of Chemistry, Molecular Biology & Biochemistry, University of California, Irvine | Conference Chairman

Url: http://www.healthtech.com/

Cambridge Healthtech Institute's Seventh Annual Fragment-Based Drug Discovery ( 8:00 am )
Finding fragments by various screening methods has become an established practice. Each of the technologies used have a different set of advantages and disadvantages. Questions such as how to select the most suitable projects, how and when to use screening methods such as crystallography, NMR, SPR or mass spec either as a standalone technique or in combination and how to correctly predict binding at active sites will be addressed in this meeting. In addition, new challenges are arising and will be discussed, such as fragment docking, fragment library design, ligand efficiency, fragment selecitivity and specificity.

Contact Info : 250 First Avenue Suite 300 Needham, MA 02494 P: 781.972.5400 F: 781.972.5425 Email : Url: https://chidb.com/register/2012/dch/reg.asp

Immunogenicity For Biotherapeutics ( 8:00 am )

The Largest and Longest-Running Event Devoted to Designing Reliable Assays and Safer Molecules, and Setting Industry-Leading Strategies to Ensure the Safety of Follow-On Biologics

Now in its 13th year, "Immunogenicity for Biotherapeutics" is the one event that helps you target the most valid and efficient methods in order to yield consistent and reliable results.

Contact Info : To learn more about exhibiting, please call Business Development Manager, Adam Lennon, at 646.895.7475 Email : Url: http://www.iirusa.com/

BIO IP Counsels Committee Conference ( 8:00 am )

IP Counsels Committee Conference Overview

Over the past nine years, BIO's semiannual IP Counsels Committee Conference has become a popular and growing event among our members' IP and legal professionals. Our upcoming 2012 Spring IPCC Conference in Austin, Texas will be an excellent opportunity for IP professionals to hear, listen, and learn about current and projected topics related to biotechnology IP.

We invite you to join us in an informal, fun and informative setting to meet fellow in-house legal and IP professionals, to make new acquaintances, to reconnect with old friends in the industry, and to take home a wealth of information - and maybe some new ideas.

Contact Info : Caroline Boch (202) 962-9228 Email : Url: http://login.bio.org/?redirectKey=product&extra=1423

Biologics World Korea ( 8:00 am )

Biologics World Korea provides the ONLY biologics and biosimilars focused platform in Korea that brings together Korean and international biopharma leaders, innovative biotechs, and technocrats to convene and discuss on strategies, latest technologies and best practices.

Biologics World Korea 2012 brings you:

• The most targeted platform to meet Korean and international biologics manufacturers

• Case studies and discussions from senior level decision makers who will influence the direction of Korea's biologics industry

• Both strategic and technology-focused biologics development in Korea

Biologics World Korea 2012 Key topics include:

• Opportunities and challenges facing Korea Biologics Industry

• Innovation highlights: Biobetters and novel biologics development in Korea

• Innovation highlights: Vaccine Development in Korea

• Biomanufacturing upstream best practices

• Biomanufacturing downstream best practices

• Operational excellence and PAT

• Crystalballing the future of Korean industry

Contact Info : Jasmine Wong +65 6493 1598 Email : Url: http://www.imapac.com/index.php?page=Biologics-World-Korea-2012Enquiry

Cambridge Healthtech Institute's Seventh Annual Fragment-Based Drug Discovery ( 8:00 am )
Finding fragments by various screening methods has become an established practice. Each of the technologies used have a different set of advantages and disadvantages. Questions such as how to select the most suitable projects, how and when to use screening methods such as crystallography, NMR, SPR or mass spec either as a standalone technique or in combination and how to correctly predict binding at active sites will be addressed in this meeting. In addition, new challenges are arising and will be discussed, such as fragment docking, fragment library design, ligand efficiency, fragment selecitivity and specificity.

Contact Info : 250 First Avenue Suite 300 Needham, MA 02494 P: 781.972.5400 F: 781.972.5425 Email : Url: https://chidb.com/register/2012/dch/reg.asp

Immunogenicity For Biotherapeutics ( 8:00 am )

The Largest and Longest-Running Event Devoted to Designing Reliable Assays and Safer Molecules, and Setting Industry-Leading Strategies to Ensure the Safety of Follow-On Biologics

Now in its 13th year, "Immunogenicity for Biotherapeutics" is the one event that helps you target the most valid and efficient methods in order to yield consistent and reliable results.

Contact Info : To learn more about exhibiting, please call Business Development Manager, Adam Lennon, at 646.895.7475 Email : Url: http://www.iirusa.com/

Innovative Sample Prep And Target Enrichment In Clinical Diagnostics ( 8:00 am )

Pre-analytical processing is a pivotal part of clinical diagnostics. Its modernization should closely follow or even precede the emergence of new diagnostic technologies. Target enrichment as part of pre-analytical processing has the ability to significantly increase sensitivity and specificity of a test that is run on a heterogeneous sample or a sample that contains a low concentration of analyte. This conference is designed to demonstrate the latest advances in pre-analytical processing, sample preparation and target enrichment for clinical laboratory testing.

TOPICS INCLUDE:

• Pre-Analytical Challenges in Point-of-Care Testing
• Sample Prep and Target Enrichment in Molecular Diagnostics for Infectious Diseases
• Sample Prep and Target Enrichment in Molecular Diagnostics of Cancer
• Pre-Analytical Issues in Mass Spectrometry Applications
• Sample Prep for Next Generation Sequencing

Url: http://www.healthtech.com/smp/

5th Annual CEE & CIS Clinical Trials Forum ( 8:30 am )

This 2-day conference will focus on the most critical issues related to the clinical trials performed in the CEE & CIS region. Increasing competitiveness by optimizing clinical trials, bioethical perspectives, regional regulatory aspects are only some topics to be discussed. The speaker panel of 16 experts from the CEE & CIS region will reveal specifics and insights into their countries' perspectives.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : Url: http://pharma.flemingeurope.com/ceecis-clinical-trials/

Biologics World Korea ( 8:00 am )

Biologics World Korea provides the ONLY biologics and biosimilars focused platform in Korea that brings together Korean and international biopharma leaders, innovative biotechs, and technocrats to convene and discuss on strategies, latest technologies and best practices.

Biologics World Korea 2012 brings you:

• The most targeted platform to meet Korean and international biologics manufacturers

• Case studies and discussions from senior level decision makers who will influence the direction of Korea's biologics industry

• Both strategic and technology-focused biologics development in Korea

Biologics World Korea 2012 Key topics include:

• Opportunities and challenges facing Korea Biologics Industry

• Innovation highlights: Biobetters and novel biologics development in Korea

• Innovation highlights: Vaccine Development in Korea

• Biomanufacturing upstream best practices

• Biomanufacturing downstream best practices

• Operational excellence and PAT

• Crystalballing the future of Korean industry

Contact Info : Jasmine Wong +65 6493 1598 Email : Url: http://www.imapac.com/index.php?page=Biologics-World-Korea-2012Enquiry

Cambridge Healthtech Institute's Seventh Annual Fragment-Based Drug Discovery ( 8:00 am )
Finding fragments by various screening methods has become an established practice. Each of the technologies used have a different set of advantages and disadvantages. Questions such as how to select the most suitable projects, how and when to use screening methods such as crystallography, NMR, SPR or mass spec either as a standalone technique or in combination and how to correctly predict binding at active sites will be addressed in this meeting. In addition, new challenges are arising and will be discussed, such as fragment docking, fragment library design, ligand efficiency, fragment selecitivity and specificity.

Contact Info : 250 First Avenue Suite 300 Needham, MA 02494 P: 781.972.5400 F: 781.972.5425 Email : Url: https://chidb.com/register/2012/dch/reg.asp

Immunogenicity For Biotherapeutics ( 8:00 am )

The Largest and Longest-Running Event Devoted to Designing Reliable Assays and Safer Molecules, and Setting Industry-Leading Strategies to Ensure the Safety of Follow-On Biologics

Now in its 13th year, "Immunogenicity for Biotherapeutics" is the one event that helps you target the most valid and efficient methods in order to yield consistent and reliable results.

Contact Info : To learn more about exhibiting, please call Business Development Manager, Adam Lennon, at 646.895.7475 Email : Url: http://www.iirusa.com/

Innovative Sample Prep And Target Enrichment In Clinical Diagnostics ( 8:00 am )

Pre-analytical processing is a pivotal part of clinical diagnostics. Its modernization should closely follow or even precede the emergence of new diagnostic technologies. Target enrichment as part of pre-analytical processing has the ability to significantly increase sensitivity and specificity of a test that is run on a heterogeneous sample or a sample that contains a low concentration of analyte. This conference is designed to demonstrate the latest advances in pre-analytical processing, sample preparation and target enrichment for clinical laboratory testing.

TOPICS INCLUDE:

• Pre-Analytical Challenges in Point-of-Care Testing
• Sample Prep and Target Enrichment in Molecular Diagnostics for Infectious Diseases
• Sample Prep and Target Enrichment in Molecular Diagnostics of Cancer
• Pre-Analytical Issues in Mass Spectrometry Applications
• Sample Prep for Next Generation Sequencing

Url: http://www.healthtech.com/smp/

5th Annual CEE & CIS Clinical Trials Forum ( 8:30 am )

This 2-day conference will focus on the most critical issues related to the clinical trials performed in the CEE & CIS region. Increasing competitiveness by optimizing clinical trials, bioethical perspectives, regional regulatory aspects are only some topics to be discussed. The speaker panel of 16 experts from the CEE & CIS region will reveal specifics and insights into their countries' perspectives.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : Url: http://pharma.flemingeurope.com/ceecis-clinical-trials/

Diabetes Summit ( 8:00 am )
Dear Colleague,

The International Diabetes Federation estimates that more than 285 million people world-wide have diabetes and 438 million people will have this disease within 20 years. Type 2 Diabetes Mellitus (T2DM) accounts for more than 90% of all diabetes and is characterized by insulin resistance combined with relatively reduced insulin secretion. The seven major markets for diabetes are expected to grow to 35 billion in 10 years driven by patient population expansion and novel therapies. With more than 400 drug candidates for diabetes in active development and in light of the recent US Food and Drug Administration (FDA) guidance to assess cardiovascular risk in clinical trials, the burden to develop novel drugs is greater and the barrier for success has become higher than ever. What will be the next block-buster drug target for T1DM and T2DM? How does the recent FDA guidance affect our approach to develop new medications for diabetes? How do different size companies adapt the best strategy to be competitive in this field?

Come and join other diabetes experts at GTC’s 2nd Diabetes Summit and hear key thought-leader's opinions to these questions and many more. This important meeting will be held on April 19-20, 2012 in Boston, MA. The conference will bring together the leading experts on diabetes from both industry and academia to discuss novel targets for diabetes, lessons to learn from current clinical drug development, and business strategies and opportunities under the current regulatory landscape.

This summit includes two concurrent tracks:
5th Diabetes Drug Discovery and Development
2nd Diabetes Partnering & Deal Making

Best regards,

2012 Conference Advisory Committee

 

Url: http://www.gtcbio.com/preview/diabetes2012/main.htm

Genomics Research 2012 ( 8:00 am )
Genomics Research 2012 aims to provide a technical programme that encompasses all of the cutting edge topics within Genomics Research, with a particular focus on its application in the development of therapeutics and diagnostics.

Network with over 400 of your peers and 50 exhibiting companies to create partnerships and collaborations to advance your research. It will encompass our successful RNAi & miRNA, Advances in qPCR, Epigenetics, Next Gen Sequencing conference streams as well as and Genomic Biomarkers. This year's event will be held in Boston.

Registered delegates will have access to all five meetings ensuring a very cost-effective trip.

Click on the track of most interest to you to view the conference agenda or to submit an abstract.

Url: http://selectbiosciences.com/conferences/contactUs.aspx?conf=GR2012

5th Annual CEE & CIS Clinical Trials Forum ( 8:30 am )

This 2-day conference will focus on the most critical issues related to the clinical trials performed in the CEE & CIS region. Increasing competitiveness by optimizing clinical trials, bioethical perspectives, regional regulatory aspects are only some topics to be discussed. The speaker panel of 16 experts from the CEE & CIS region will reveal specifics and insights into their countries' perspectives.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : Url: http://pharma.flemingeurope.com/ceecis-clinical-trials/

Diabetes Summit ( 8:00 am )
Dear Colleague,

The International Diabetes Federation estimates that more than 285 million people world-wide have diabetes and 438 million people will have this disease within 20 years. Type 2 Diabetes Mellitus (T2DM) accounts for more than 90% of all diabetes and is characterized by insulin resistance combined with relatively reduced insulin secretion. The seven major markets for diabetes are expected to grow to 35 billion in 10 years driven by patient population expansion and novel therapies. With more than 400 drug candidates for diabetes in active development and in light of the recent US Food and Drug Administration (FDA) guidance to assess cardiovascular risk in clinical trials, the burden to develop novel drugs is greater and the barrier for success has become higher than ever. What will be the next block-buster drug target for T1DM and T2DM? How does the recent FDA guidance affect our approach to develop new medications for diabetes? How do different size companies adapt the best strategy to be competitive in this field?

Come and join other diabetes experts at GTC’s 2nd Diabetes Summit and hear key thought-leader's opinions to these questions and many more. This important meeting will be held on April 19-20, 2012 in Boston, MA. The conference will bring together the leading experts on diabetes from both industry and academia to discuss novel targets for diabetes, lessons to learn from current clinical drug development, and business strategies and opportunities under the current regulatory landscape.

This summit includes two concurrent tracks:
5th Diabetes Drug Discovery and Development
2nd Diabetes Partnering & Deal Making

Best regards,

2012 Conference Advisory Committee

 

Url: http://www.gtcbio.com/preview/diabetes2012/main.htm

Genomics Research 2012 ( 8:00 am )
Genomics Research 2012 aims to provide a technical programme that encompasses all of the cutting edge topics within Genomics Research, with a particular focus on its application in the development of therapeutics and diagnostics.

Network with over 400 of your peers and 50 exhibiting companies to create partnerships and collaborations to advance your research. It will encompass our successful RNAi & miRNA, Advances in qPCR, Epigenetics, Next Gen Sequencing conference streams as well as and Genomic Biomarkers. This year's event will be held in Boston.

Registered delegates will have access to all five meetings ensuring a very cost-effective trip.

Click on the track of most interest to you to view the conference agenda or to submit an abstract.

Url: http://selectbiosciences.com/conferences/contactUs.aspx?conf=GR2012

Biosimilars Asia ( 8:00 am )

IBC’s 3rd Annual Biosimilars Asia 2012 is the largest and most anticipated meeting of its kind in Asia. Attended by biosimilars, innovators, generics and biopharma alike, the unique mix of attendees from all over the world will share their experiences and opinions about the future of biosimilars. Tough questions will be answered and positions will be challenged but all will walk away bristling with ideas, opportunities and be more informed. Biosimilars Asia 2012 continues to deliver a quality of speakers and discussions unmatched in Asia.

REASONS WHY BIOSIMILARS ASIA IS A ‘MUST ATTEND’

• Biosimilars Asia 2012 is Asia’s LARGEST CONFERENCE addressing complex strategy questions, attended by regional and global innovators, generics, biopharma and biosimilars companies
• STRATEGIC PLENARY KEYNOTE SESSIONS with delegates from Biosimilars Asia 2012, China Pharmaceutical R&D Summit & Vaccines China 2012
• DON’T MISS OUT on ‘no-holds-barred’ discussions featuring innovators, generics, biosimilars and industry thoughtleaders!

Contact Info : Registration Hotline: +65 6508 2401 Url: http://www.ibc-asia.com

Biosimilars Asia ( 8:00 am )

IBC’s 3rd Annual Biosimilars Asia 2012 is the largest and most anticipated meeting of its kind in Asia. Attended by biosimilars, innovators, generics and biopharma alike, the unique mix of attendees from all over the world will share their experiences and opinions about the future of biosimilars. Tough questions will be answered and positions will be challenged but all will walk away bristling with ideas, opportunities and be more informed. Biosimilars Asia 2012 continues to deliver a quality of speakers and discussions unmatched in Asia.

REASONS WHY BIOSIMILARS ASIA IS A ‘MUST ATTEND’

• Biosimilars Asia 2012 is Asia’s LARGEST CONFERENCE addressing complex strategy questions, attended by regional and global innovators, generics, biopharma and biosimilars companies
• STRATEGIC PLENARY KEYNOTE SESSIONS with delegates from Biosimilars Asia 2012, China Pharmaceutical R&D Summit & Vaccines China 2012
• DON’T MISS OUT on ‘no-holds-barred’ discussions featuring innovators, generics, biosimilars and industry thoughtleaders!

Contact Info : Registration Hotline: +65 6508 2401 Url: http://www.ibc-asia.com

Biosimilars Asia ( 8:00 am )

IBC’s 3rd Annual Biosimilars Asia 2012 is the largest and most anticipated meeting of its kind in Asia. Attended by biosimilars, innovators, generics and biopharma alike, the unique mix of attendees from all over the world will share their experiences and opinions about the future of biosimilars. Tough questions will be answered and positions will be challenged but all will walk away bristling with ideas, opportunities and be more informed. Biosimilars Asia 2012 continues to deliver a quality of speakers and discussions unmatched in Asia.

REASONS WHY BIOSIMILARS ASIA IS A ‘MUST ATTEND’

• Biosimilars Asia 2012 is Asia’s LARGEST CONFERENCE addressing complex strategy questions, attended by regional and global innovators, generics, biopharma and biosimilars companies
• STRATEGIC PLENARY KEYNOTE SESSIONS with delegates from Biosimilars Asia 2012, China Pharmaceutical R&D Summit & Vaccines China 2012
• DON’T MISS OUT on ‘no-holds-barred’ discussions featuring innovators, generics, biosimilars and industry thoughtleaders!

Contact Info : Registration Hotline: +65 6508 2401 Url: http://www.ibc-asia.com

Biosimilars Asia ( 8:00 am )

IBC’s 3rd Annual Biosimilars Asia 2012 is the largest and most anticipated meeting of its kind in Asia. Attended by biosimilars, innovators, generics and biopharma alike, the unique mix of attendees from all over the world will share their experiences and opinions about the future of biosimilars. Tough questions will be answered and positions will be challenged but all will walk away bristling with ideas, opportunities and be more informed. Biosimilars Asia 2012 continues to deliver a quality of speakers and discussions unmatched in Asia.

REASONS WHY BIOSIMILARS ASIA IS A ‘MUST ATTEND’

• Biosimilars Asia 2012 is Asia’s LARGEST CONFERENCE addressing complex strategy questions, attended by regional and global innovators, generics, biopharma and biosimilars companies
• STRATEGIC PLENARY KEYNOTE SESSIONS with delegates from Biosimilars Asia 2012, China Pharmaceutical R&D Summit & Vaccines China 2012
• DON’T MISS OUT on ‘no-holds-barred’ discussions featuring innovators, generics, biosimilars and industry thoughtleaders!

Contact Info : Registration Hotline: +65 6508 2401 Url: http://www.ibc-asia.com

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : peter.novak@flemingeurope.com Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : peter.novak@flemingeurope.com Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : peter.novak@flemingeurope.com Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : peter.novak@flemingeurope.com Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : peter.novak@flemingeurope.com Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : peter.novak@flemingeurope.com Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : peter.novak@flemingeurope.com Url: http://pharma.flemingeurope.com/innovation-pharma-rd/

Open Innovation In Pharmaceutical R&D ( 8:00 am )

This conference is looking for an ideal solution to the productivity crisis in pharma. Eighteen top-level speakers from Pfizer, Novartis, Sanofi, GlaxoSmithKline, and others will reveal the methods on how to use open innovation to innovate exponentially without expanding R&D investment and accelerate the development of life-saving medicines. They will share their own experiences in panel discussions.

Contact Info : Tel: +421 257 272 110 Fax: +421 255 644 490 Email : peter.novak@flemingeurope.com Url: http://pharma.flemingeurope.com/innovation-pharma-rd/